Evaluation of Pharmaceutical Quality of Mesalamine Delayed Release Tablets Using a New High Sensitivity Reversed-Phase UPLC Method for its Genotoxic/Aniline Impurity
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.